Embolization polymer, novel blood vessel embolization chemotherapy composite as well as preparation and application of novel blood vessel embolization chemotherapy composite

A vascular embolization and polymer technology, applied in the field of interventional medicine, can solve the problems of affecting the physicochemical properties and embolization performance of microspheres, unable to complete chemoembolization treatment in one step, and complicated embolization operation of emulsion-embolizing agent, etc. Wide temperature range and improved curative effect

Inactive Publication Date: 2018-12-21
深圳市比德泰克生物医药科技有限公司
View PDF5 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are several main defects in traditional TACE treatment: ① lipiodol emulsion will have local deposition, and as time goes on, the cytotoxic effect of the drug on the tumor will also decrease; ② although the emulsion reduces systemic adverse reactions compared with traditional chemotherapy, it still has Some drugs enter the circulatory system, increasing adverse reactions; ③In tumor treatment, the therapeutic effect requires maintaining a certain drug concentration inside the tumor, and this depends on the sustained release of drugs, which is difficult for lipiodol emulsions; ④Emulsion-Embolism The embolization operation is complicated, and chemoembolization cannot be completed in one step
Generally, the polymerization reaction is greatly affected by the chemical structure, degree of alcoholysis, degree of polymerization, molecular weight and viscosity of polymer materials, which makes the synthesis process of microspheres difficult to control, which in turn affects the physical and chemical properties and embolism properties of microspheres.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Embolization polymer, novel blood vessel embolization chemotherapy composite as well as preparation and application of novel blood vessel embolization chemotherapy composite
  • Embolization polymer, novel blood vessel embolization chemotherapy composite as well as preparation and application of novel blood vessel embolization chemotherapy composite
  • Embolization polymer, novel blood vessel embolization chemotherapy composite as well as preparation and application of novel blood vessel embolization chemotherapy composite

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Embodiment 1: the preparation of microsphere

[0042] Using the reverse phase suspension polymerization method, add 60mL liquid paraffin and 60mg Span 80 into the three-necked flask, blow nitrogen to drive oxygen, and then dissolve 4.0g hydroxyethyl methacrylate, 2.0g acrylic acid, 60mg N,N'- Add methylenebisacrylamide (crosslinking agent) and 60mg ammonium persulfate (initiator) solution dropwise to the oil phase at 70°C, and after pre-crosslinking for 15 minutes, add 60mg tetramethylethylenediamine (catalyst) , after reacting for 2.5 hours under stirring at 200rpm, separate the microspheres, wash them, sieve out different specifications according to the particle size, and collect the particle size ranges (50~100μm, 100~300μm, 300~500μm, 500~700μm, 700~ 900μm, 900~1250μm and >1250μm) microspheres. Observe its shape, size and adhesion under an optical microscope, such as figure 1 As shown, the prepared microspheres are colorless, transparent, regular-shaped, circular ...

Embodiment 2

[0043] Embodiment 2: the preparation of microsphere

[0044] Using the reverse phase suspension polymerization method, add 60mL of liquid paraffin and 75mg of Span 80 into a three-necked flask, pass through nitrogen to drive oxygen, and then dissolve 4.0g of methyl methacrylate, 4.0g of 2-acrylamide-2-methyl Add propanesulfonic acid, 75mg N,N'-methylenebisacrylamide (crosslinking agent) and 75mg ammonium persulfate (initiator) solution dropwise to the oil phase at 80°C, pre-crosslink for 15min, then add 75 mg of tetramethylethylenediamine (catalyst), reacted for 4 hours under stirring at 300 rpm, separated the microspheres, washed, sieved out different specifications according to particle size, and collected various particle size ranges (50-100 μm, 100-300 μm, 300-500 μm, 500-700 μm, 700-900 μm, 900-1250 μm and >1250 μm) microspheres.

Embodiment 3

[0045] Example 3: Fracture deformation of microspheres

[0046] The physical property analyzer is equipped with a probe with a diameter of 6mm; the maximum bearing force of the sensing element is 5N, the minimum sensing force is 0.001N, and the accuracy is 0.01N; the sensing element collects 100 data points per second during the test. During the experiment, the probe of the physical property analyzer is controlled to compress the microspheres at a certain speed, and the resistance of the microspheres is converted into electrical signals through the sensor element, and the data is recorded online through the computer. The single microsphere compression test is used to test the stress and microsphere rupture of a single microsphere when subjected to a large deformation.

[0047] Take the single microspheres prepared in Example 1, with a particle size of 700 μm, and place them on the platform. The probe starts to press down from a height of 700 μm at a speed of 0.01 mm / s, and sto...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle diameteraaaaaaaaaa
concentrationaaaaaaaaaa
Login to view more

Abstract

The invention provides an embolization polymer. The embolization polymer is prepared by performing polymerization reaction initiated by free radicals on micromolecule monomer containing unsaturated double bonds, monomer containing unsaturated double bonds and an optional cross-linking agent; the cross-linking agent is polyfunctionality water-soluble acrylate or acrylamide. The embolization polymeris an ion exchange microsphere carrier and has higher deformation ability and higher drug trapping efficiency and drug loading capacity; meanwhile, a slow release effect is better. The invention further provides a novel blood vessel embolization chemotherapy composite. The embolization chemotherapy composite disclosed by the invention can jointly deliver an embolization agent and chemotherapy drug to a target blood vessel part through a catheter, so that a curative effect of the chemotherapy drug is fully played, peripheral normal tissues are prevented from being damaged, and disease relapsing is reduced.

Description

technical field [0001] The invention belongs to the field of interventional medicine, and relates to an embolic polymer, a novel vascular embolization chemotherapy composition, a preparation method and application thereof. Background technique [0002] Interventional radiology is a new discipline developed in recent years. It is a minimally invasive medical technology guided by imaging equipment. It has the characteristics of small trauma, fast recovery, and good curative effect. treatment pathway. At present, it has become the three most important therapeutic disciplines along with internal medicine and surgery. Interventional embolization is an important part of interventional therapy, and it is increasingly playing an important role in the treatment of malignant tumors, vascular malformations, uterine fibroids and hemostasis. [0003] Arterial chemoembolization, or TACE treatment, combines embolization and chemotherapy. It is a non-surgical and minimally invasive tumor ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C08F220/20C08F220/06C08F222/38C08F220/14C08F220/58A61K31/704A61K31/4745A61P35/00A61L24/06A61L24/00
CPCA61K31/4745A61K31/704A61L24/0015A61L24/06A61L2300/216A61L2300/23A61L2300/416A61P35/00C08F220/14C08F220/20C08F220/06C08F222/385C08F220/585
Inventor 杜玲然余宗峻严立标黄剑文黄玉刚周毅付纪军
Owner 深圳市比德泰克生物医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products